THC use was linked to altered DNA methylation patterns in schizophrenia-related genes
Treatment-resistant schizophrenia patients who used THC showed different DNA methylation patterns in the NRXN1 and MAPT genes compared to non-using patients and healthy controls.
Quick Facts
What This Study Found
In the NRXN1 gene promoter, THC-consuming schizophrenia patients had nearly double the methylation rate compared to non-consuming patients. In MAPT, non-consumer patients had lower methylation than controls (possibly compensatory), but THC consumers had rates closer to controls. NRG1 and DISC1 showed no group differences, and DISC1 appeared unmethylated across all groups.
Key Numbers
50 treatment-resistant schizophrenia patients. NRXN1 methylation: THC consumers nearly 2x higher than non-consumers. MAPT methylation: lower in non-consumer patients vs. controls, less difference in THC consumers. NRG1 and DISC1: no significant group differences.
How They Did This
Case-control study of 50 treatment-resistant schizophrenia outpatients (THC consumers and non-consumers) and healthy controls. DNA from blood samples was bisulfite-converted and sequenced to measure promoter methylation of four schizophrenia candidate genes: NRG1, NRXN1, DISC1, and MAPT.
Why This Research Matters
Epigenetic changes (like DNA methylation) can alter gene expression without changing the DNA sequence. Finding that THC use is associated with different methylation patterns in synaptic genes suggests a potential molecular mechanism linking cannabis to schizophrenia biology.
The Bigger Picture
The NRXN1 finding is particularly interesting because neurexin-1 is essential for synapse formation and function, and NRXN1 disruptions have been independently linked to schizophrenia. THC-associated hypermethylation could theoretically reduce NRXN1 expression and worsen synaptic deficits.
What This Study Doesn't Tell Us
Small sample size. Cross-sectional design cannot determine whether THC caused the methylation changes. Blood-based methylation may not reflect brain methylation. Treatment-resistant population may not be representative.
Questions This Raises
- ?Do these methylation changes reflect THC effects on the brain?
- ?Would the methylation patterns reverse with cannabis cessation?
- ?Are NRXN1 methylation levels correlated with symptom severity?
Trust & Context
- Key Stat:
- NRXN1 methylation nearly 2x higher in THC-consuming schizophrenia patients
- Evidence Grade:
- Small sample with cross-sectional design. Novel epigenetic finding but cannot establish causation.
- Study Age:
- 2021 epigenetic study from French and German institutions.
- Original Title:
- Differential Methylation Pattern of Schizophrenia Candidate Genes in Tetrahydrocannabinol-Consuming Treatment-Resistant Schizophrenic Patients Compared to Non-Consumer Patients and Healthy Controls.
- Published In:
- Neuropsychobiology, 80(1), 36-44 (2021)
- Authors:
- Jahn, Kirsten(2), Heese, Astrid, Kebir, Oussama(3), Groh, Adrian, Bleich, Stefan, Krebs, Marie Odile, Frieling, Helge
- Database ID:
- RTHC-03217
Evidence Hierarchy
Compares people with a condition to similar people without it.
What do these levels mean? →Frequently Asked Questions
What is DNA methylation?
DNA methylation is a chemical modification that can turn genes on or off without changing the DNA sequence itself. Higher methylation in a gene promoter typically reduces that gene's activity.
Why is the NRXN1 finding important?
NRXN1 codes for neurexin-1, a protein essential for synapse formation. Higher methylation could reduce its expression, potentially worsening the synaptic connectivity deficits already seen in schizophrenia.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
Cite This Study
https://rethinkthc.com/research/RTHC-03217APA
Jahn, Kirsten; Heese, Astrid; Kebir, Oussama; Groh, Adrian; Bleich, Stefan; Krebs, Marie Odile; Frieling, Helge. (2021). Differential Methylation Pattern of Schizophrenia Candidate Genes in Tetrahydrocannabinol-Consuming Treatment-Resistant Schizophrenic Patients Compared to Non-Consumer Patients and Healthy Controls.. Neuropsychobiology, 80(1), 36-44. https://doi.org/10.1159/000507670
MLA
Jahn, Kirsten, et al. "Differential Methylation Pattern of Schizophrenia Candidate Genes in Tetrahydrocannabinol-Consuming Treatment-Resistant Schizophrenic Patients Compared to Non-Consumer Patients and Healthy Controls.." Neuropsychobiology, 2021. https://doi.org/10.1159/000507670
RethinkTHC
RethinkTHC Research Database. "Differential Methylation Pattern of Schizophrenia Candidate ..." RTHC-03217. Retrieved from https://rethinkthc.com/research/jahn-2021-differential-methylation-pattern-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.